Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peginesatide in patients with anemia undergoing hemodialysis.
Fishbane S, Schiller B, Locatelli F, Covic AC, Provenzano R, Wiecek A, Levin NW, Kaplan M, Macdougall IC, Francisco C, Mayo MR, Polu KR, Duliege AM, Besarab A; EMERALD Study Groups. Fishbane S, et al. Among authors: duliege am. N Engl J Med. 2013 Jan 24;368(4):307-19. doi: 10.1056/NEJMoa1203165. N Engl J Med. 2013. PMID: 23343061 Free article. Clinical Trial.
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.
Macdougall IC, Provenzano R, Sharma A, Spinowitz BS, Schmidt RJ, Pergola PE, Zabaneh RI, Tong-Starksen S, Mayo MR, Tang H, Polu KR, Duliege AM, Fishbane S; PEARL Study Groups. Macdougall IC, et al. Among authors: duliege am. N Engl J Med. 2013 Jan 24;368(4):320-32. doi: 10.1056/NEJMoa1203166. N Engl J Med. 2013. PMID: 23343062 Free article. Clinical Trial.
Peginesatide for anemia in chronic kidney disease.
Macdougall IC, Fishbane S, Duliege AM. Macdougall IC, et al. Among authors: duliege am. N Engl J Med. 2013 Apr 18;368(16):1553-4. doi: 10.1056/NEJMc1302314. N Engl J Med. 2013. PMID: 23594010 No abstract available.
A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.
Macdougall IC, Rossert J, Casadevall N, Stead RB, Duliege AM, Froissart M, Eckardt KU. Macdougall IC, et al. Among authors: duliege am. N Engl J Med. 2009 Nov 5;361(19):1848-55. doi: 10.1056/NEJMoa074037. N Engl J Med. 2009. PMID: 19890127 Free article. Clinical Trial.
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients.
Macdougall IC, Wiecek A, Tucker B, Yaqoob M, Mikhail A, Nowicki M, MacPhee I, Mysliwiec M, Smolenski O, Sułowicz W, Mayo M, Francisco C, Polu KR, Schatz PJ, Duliege AM. Macdougall IC, et al. Among authors: duliege am. Clin J Am Soc Nephrol. 2011 Nov;6(11):2579-86. doi: 10.2215/CJN.10831210. Epub 2011 Sep 22. Clin J Am Soc Nephrol. 2011. PMID: 21940838 Free PMC article. Clinical Trial.
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.
Stead RB, Lambert J, Wessels D, Iwashita JS, Leuther KK, Woodburn KW, Schatz PJ, Okamoto DM, Naso R, Duliege AM. Stead RB, et al. Among authors: duliege am. Blood. 2006 Sep 15;108(6):1830-4. doi: 10.1182/blood-2006-04-015818. Epub 2006 May 23. Blood. 2006. PMID: 16720830 Free article. Clinical Trial.
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.
Bussel J, Arnold DM, Grossbard E, Mayer J, Treliński J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM. Bussel J, et al. Among authors: duliege am. Am J Hematol. 2018 Jul;93(7):921-930. doi: 10.1002/ajh.25125. Epub 2018 May 15. Am J Hematol. 2018. PMID: 29696684 Free PMC article. Clinical Trial.
52 results